Merck settlement includes ACCME policies agreement

Share this article:
Merck's settlement of Vioxx litigation with 29 states included agreements to abide by ACCME policies regarding disclosure of relationships between speakers and companies and not to fund programs featuring speakers who have spoken at a Merck-sponsored promotional event on a drug in the relevant class within the last 12 months. The settlement commits Merck to these conditions for nine years. 

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions